Information about methionne administration in the clinical study
Clinical studies
Patients with colorectal cancer were recruited for the methionine
supplementation study. Eligible patients were of Eastern Cooperative
Oncology Group performance status 0/1 with adequate organ
and bone marrow function. Patients were excluded from this study if
they had received or were receiving any concurrent chemotherapy,
immunotherapy, biologic, and/or hormonal therapy for cancer. All
patients took two capsules of methionine (500 mg per capsule, NOW
Foods) daily for two weeks.
Information about methionne administration in the clinical study
Clinical studies
Patients with colorectal cancer were recruited for the methionine
supplementation study. Eligible patients were of Eastern Cooperative
Oncology Group performance status 0/1 with adequate organ
and bone marrow function. Patients were excluded from this study if
they had received or were receiving any concurrent chemotherapy,
immunotherapy, biologic, and/or hormonal therapy for cancer. All
patients took two capsules of methionine (500 mg per capsule, NOW
Foods) daily for two weeks.